| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Edetate (substance) |
Is a |
True |
Chelating agent |
Inferred relationship |
Some |
|
| Deferoxamine (substance) |
Is a |
True |
Chelating agent |
Inferred relationship |
Some |
|
| Trientine (substance) |
Is a |
True |
Chelating agent |
Inferred relationship |
Some |
|
| Chelating agent poisoning |
Causative agent (attribute) |
False |
Chelating agent |
Inferred relationship |
Some |
1 |
| Accidental chelating agent poisoning |
Causative agent (attribute) |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Intentional chelating agent poisoning |
Causative agent (attribute) |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Chelating agent poisoning of undetermined intent |
Causative agent (attribute) |
False |
Chelating agent |
Inferred relationship |
Some |
1 |
| Chelating agent adverse reaction |
Causative agent (attribute) |
True |
Chelating agent |
Inferred relationship |
Some |
1 |
| Desferrioxamine adverse reaction |
Causative agent (attribute) |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Allergy to chelating agent |
Causative agent (attribute) |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing chelating agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chelating agent |
Inferred relationship |
Some |
1 |
| Dimercaprol (substance) |
Is a |
True |
Chelating agent |
Inferred relationship |
Some |
|
| Penicillamine (substance) |
Is a |
True |
Chelating agent |
Inferred relationship |
Some |
|
| Deferiprone (substance) |
Is a |
True |
Chelating agent |
Inferred relationship |
Some |
|
| Edetate trisodium (substance) |
Is a |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing mesna (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing methionine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing fomepizole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing alcohol dehydrogenase inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing mercaptamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing ipecacuanha (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Pediatric ipecacuanha emetic mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Activated charcoal oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing Fuller's earth (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Fuller's earth powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing sodium nitrite (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Sodium nitrite 30mg/mL injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Sodium thiosulfate 12.5g/25mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Pralidoxime mesylate 200mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing digoxin immune fab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Protamine sulfate 50mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Protamine sulfate 100mg/10mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Flumazenil 100micrograms/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Methionine 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Methionine 250 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Apomorphine hydrochloride 10mg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Apomorphine hydrochloride 10mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Apomorphine hydrochloride 30mg/3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Naltrexone hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Drugs used in the treatment of paracetamol poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Acetylcysteine 200mg/mL infusion solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Methionine 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Mesna 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Mesna 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Mesna 100mg/mL injection solution 4mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Mesna 100mg/mL injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Calcium polystyrene sulfonate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Sodium polystyrene sulfonate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing sevelamer (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing precisely sevelamer 400 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing precisely mercaptamine (as mercaptamine bitartrate) 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing precisely mercaptamine (as mercaptamine bitartrate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Naloxone hydrochloride 400mcg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Naloxone hydrochloride 400mcg/mL injection solution 2mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Naloxone hydrochloride 400mcg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Naloxone hydrochloride 20mcg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing calcium polystyrene sulfonate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Chelating agents and antidotes |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing cholinesterase reactivator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Hydrofluoric acid burn antidote |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Activated charcoal powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing ion exchange resin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing cation exchange resin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Antidotes for pesticides |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Bentonite powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Cyanide antidote |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Cysteamine 0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing opioid receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing polyvalent crotalidae antivenom (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing potassium exchange resin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Polyvalent snake antivenin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Ammonia detoxicant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing heavy metal antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing sodium polystyrene sulfonate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing calcium exchange resin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing sodium thiosulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing nalorphine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing Micrurus fulvius antivenom (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing apomorphine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing snake antivenom immunoglobulin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Medicinal product acting as emetic agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing cellulose sodium phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing naltrexone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing naloxone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Medicinal product acting as antidote agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing pralidoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing benzodiazepine receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Product containing flumazenil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Emetics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Medicinal product acting as adsorbent agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Cyanide poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Heavy metal poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Organophosphorus poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Pralidoxime mesylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Polystyrene sulfonate resins |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Iron poisoning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Apomorphine hydrochloride [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
| Apomorphine hydrochloride 2 mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chelating agent |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]